Morgan Stanley Call 113 AMD 20.09.../ DE000ME2QKQ6 /
| 5/21/2024 9:16:10 PM | Chg.-0.05 | Bid9:42:55 PM | Ask9:42:55 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 8.63EUR | -0.58% | 8.63 Bid Size: 10,000 |
8.65 Ask Size: 10,000 |
Advanced Micro Devic... | 113.00 USD | 9/20/2024 | Call |
GlobeNewswire
5:30 PM
AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire
3:00 PM
AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire
1:30 PM
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from ...
GlobeNewswire
1:05 PM
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
12:55 PM
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
GlobeNewswire
5/20
Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp
5/16
FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire
5/15
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire
5/14
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
5/14
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/13
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire
5/13
AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire
5/9
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/9
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire
5/8
Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire
5/8
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
5/8
AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...
GlobeNewswire
5/8
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
GlobeNewswire
5/8
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
